Interventional management of in-stent thrombosis after superior mesenteric vein stenting

Research output: Contribution to journalArticle


Introduction: Mesenteric vein stenosis and thrombosis are rare conditions, without a definite treatment strategy. Report: A 46 year-old man underwent pancreatic resection with a polytetrafluoroethylene (PTFE) graft vascular reconstruction; he subsequently developed anastomotic mesenteric vein stenosis, which was treated with transhepatic venoplasty and stenting. Three months later, he suffered an in-stent thrombosis, after a reduction in heparin dosage. The thrombosis was successfully managed, after a failed systemic thrombolysis, with a direct thrombolysis via transjugular approach. At 10 months' follow-up, the stent was still patent. Conclusion: Mesenteric vein stenting is effective on PTFE grafts, but appropriate anticoagulation is helpful to avoid subsequent in-stent thrombosis.

Original languageEnglish
JournalEJVES Extra
Issue number3
Publication statusPublished - Sep 2011


  • Direct thrombolysis
  • Mesenteric vein stenosis
  • Stenting

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Fingerprint Dive into the research topics of 'Interventional management of in-stent thrombosis after superior mesenteric vein stenting'. Together they form a unique fingerprint.

  • Cite this